IHC of INSM1 on an FFPE Neuroendocrine Lung Carcinoma Tissue
|Intended Use||For In Vitro Diagnostic Use|
|Summary and Explanation||Insulinoma-associated 1 (INSM1) gene encodes a protein containing both a zinc finger DNA-binding domain and a putative prohormone domain, originally isolated from a human insulinoma-glucagonoma subtraction library. INSM1 mRNA is abundantly expressed in fetal NE developmental tissues and expressed in normal adult neuroendocrine tissues (adrenal medulla, pineal gland, pituitary gland, gastrointestinal enterochromaffin cells, pancreatic islet cells, thyroid C cells) and developing neurons, however there is also a high occurrence of INSM1 found in NE tumors, such as Small Cell Lung Cancer (SCLC), Pituitary tumors, Medullary Thyroid Carcinoma, Merkel Cell Carcinoma, Olfactory Neuroblastoma and Pheochromocytoma.
It has been reported that INSM1 expresses exclusively in SCLC specimens using immunohistochemistry, and first elucidated that INSM1 regulates the NE differentiation pathway in lung cancer. In addition, it has demonstrated an increased sensitivity and specificity compared to other NE biomarkers (Chromogranin A, Synaptophysin and CD56) in lung cancer specimens. In addition, it’s been shown to be involved in NE differentiation in medullary thyroid carcinoma, pheochromocytoma, intestinal NE carcinoma, islet cell tumor, pituitary tumor, and SCLC cell lines.
|Antibody Type||Mouse Monoclonal||Clone||BSB-123|
|Localization||Nuclear||Control||Pancreas, Colon, Tonsil, Neuroendocrine Lung Cancer, Endometrial & Colon Carcinomas|
|Presentation||INSM1 is a mouse monoclonal antibody derived from cell culture supernatant that is concentrated, dialyzed, filter sterilized and diluted in buffer pH 7.5, containing BSA and sodium azide as a preservative.|
|Note: For concentrated antibodies, please centrifuge prior to use to ensure recovery of all product.|